The endogenous peptides of normal human serum extracted from the acetonitrile-insoluble precipitate using modified aqueous buffer with analysis by LC-ESI-Paul ion trap and Qq-TOF.

Many peptides of biological or medicinal importance may be derived from proteolytic actions and are found at low concentrations in human blood fluids. Endogenous polypeptides from human serum were precipitated in acetonitrile and the precipitate was then selectively extracted with water modified by organic solvents and collected over C18 resin. Extraction of serum with C18 alone, and the acetonitrile supernatant or ultrafiltration collected over C18, served as controls. The samples were analyzed by SDS-PAGE, or C18 high pressure liquid chromatography with electrospray ionization using a Paul ion trap and Qq-TOF. Spectra were correlated without specifying an enzyme using the X!TANDEM or the Paragon algorithms. Multiple endogenous peptides from plasminogen, coagulation factors, collagens, serum amyloid, receptors, zinc finger/bromo peptide proteins, ryanodine receptor, calmodulin binding activator, erythroid differentiation factor, testes cancer antigen, extracellular matrix protein, myeloid/lymphoid leukemia 2 and many low abundance proteins were correlated by X!TANDEM with protein expect values of approximately E-16 or less. Proteins with binding sites for nucleic acids, phosphoinositides, and other cellular locations were also observed using the Qq-TOF and Paragon algorithm. Proteins with low expectation scores and overlapping peptides sequences were observed. The existence of these proteins in serum has been confirmed by tryptic digestion and LC-ESI-MS/MS. The presence of plasminogen, serum amyloid and zinc finger RNA binding proteins were confirmed by Western blot. There was agreement on the detection of endogenous peptides from low abundance proteins associated with the biology of cancer from the examination of the blood peptides by ion trap and Qq-TOF, tryptic digests of blood proteins, and Western blot.

[1]  W. Hancock,et al.  Study of the human plasma proteome of rheumatoid arthritis. , 2009, Journal of chromatography. A.

[2]  Paul Tempst,et al.  Data analysis of assorted serum peptidome profiles , 2007, Nature Protocols.

[3]  P. Højrup,et al.  Rapid identification of proteins by peptide-mass fingerprinting , 1993, Current Biology.

[4]  Richard D. Smith,et al.  Advances and Challenges in Liquid Chromatography-Mass Spectrometry-based Proteomics Profiling for Clinical Applications* , 2006, Molecular & Cellular Proteomics.

[5]  Alexey I Nesvizhskii,et al.  Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. , 2002, Analytical chemistry.

[6]  Anita Saraf,et al.  Reducing agent-mediated precipitation of high-abundance plasma proteins. , 2009, Analytical biochemistry.

[7]  G. Stafford Instrumental aspects of positive and negative ion chemical ionization mass spectrometry. , 1980, Environmental health perspectives.

[8]  M. Fälth,et al.  SwePep, a Database Designed for Endogenous Peptides and Mass Spectrometry* , 2006, Molecular & Cellular Proteomics.

[9]  Sean L Seymour,et al.  The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass Spectra*S , 2007, Molecular & Cellular Proteomics.

[10]  G. Qian,et al.  Inhibition of proliferation and apoptosis induced by a Na+/H+ exchanger-1 (NHE-1) antisense gene on drug-resistant human small cell lung cancer cells. , 2009, Oncology reports.

[11]  T. Veenstra,et al.  Enrichment of low-molecular-weight proteins from biofluids for biomarker discovery , 2005, Expert review of proteomics.

[12]  Ronald J Moore,et al.  Characterization of the human blood plasma proteome , 2005, Proteomics.

[13]  K. Evans,et al.  Endogenous peptides from biophysical and biochemical fractionation of serum analyzed by matrix-assisted laser desorption/ionization and electrospray ionization hybrid quadrupole time-of-flight. , 2007, Analytical biochemistry.

[14]  P. Chueh,et al.  Molecular cloning and characterization of a tumor-associated, growth-related, and time-keeping hydroquinone (NADH) oxidase (tNOX) of the HeLa cell surface. , 2002, Biochemistry.

[15]  Christoph H Borchers,et al.  Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma , 2009, Nature Biotechnology.

[16]  N. Seidah,et al.  Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels* , 2008, Journal of Biological Chemistry.

[17]  D. Chan,et al.  Identification of tumor‐associated plasma biomarkers using proteomic techniques: From mouse to human , 2004, Proteomics.

[18]  V. Castronovo,et al.  Low dentin matrix protein 1 expression correlates with skeletal metastases development in breast cancer patients and enhances cell migratory capacity in vitro , 2007, Breast Cancer Research and Treatment.

[19]  M. Baker,et al.  Evaluation of endogenous plasma peptide extraction methods for mass spectrometric biomarker discovery. , 2007, Journal of proteome research.

[20]  P. Tempst,et al.  A Sequence-specific Exopeptidase Activity Test (SSEAT) for “Functional” Biomarker Discovery*S , 2008, Molecular & Cellular Proteomics.

[21]  E. Diamandis,et al.  Comparison of protein expression lists from mass spectrometry of human blood fluids using exact peptide sequences versus BLAST , 2006, Clinical Proteomics.

[22]  Weimin Zhu,et al.  Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. , 2003, Journal of proteome research.

[23]  Christoph Menzel,et al.  Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. , 2005, Combinatorial chemistry & high throughput screening.

[24]  M. Schrader,et al.  Detection of low-molecular-mass plasma peptides in the cavernous and systemic blood of healthy men during penile flaccidity and rigidity--an experimental approach using the novel differential peptide display technology. , 2002, Urology.

[25]  J. G. Patton,et al.  Cloning and characterization of PSF, a novel pre-mRNA splicing factor. , 1993, Genes & development.

[26]  Ralph S Freedman,et al.  Ovarian cancer, the coagulation pathway, and inflammation , 2005, Journal of Translational Medicine.

[27]  H. Perreault,et al.  Characterization of plasma proteins adsorbed onto biomaterials. By MALDI-TOFMS. , 2000, Biomaterials.

[28]  E. Diamandis,et al.  Comparison of methods to examine the endogenous peptides of fetal calf serum , 2006, Clinical Proteomics.

[29]  R. Aebersold,et al.  A statistical model for identifying proteins by tandem mass spectrometry. , 2003, Analytical chemistry.

[30]  J. Nezu,et al.  A novel family of bromodomain genes. , 2000, Genomics.

[31]  Yanlei Ma,et al.  Proteomics Identification of Desmin as a Potential Oncofetal Diagnostic and Prognostic Biomarker in Colorectal Cancer* , 2009, Molecular & Cellular Proteomics.

[32]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[33]  A. Nesvizhskii,et al.  Experimental protein mixture for validating tandem mass spectral analysis. , 2002, Omics : a journal of integrative biology.

[34]  I. Behrmann,et al.  A cost effective non-commercial ECL-solution for Western blot detections yielding strong signals and low background. , 2007, Journal of immunological methods.

[35]  Harald Tammen,et al.  Specimen Collection and Handling , 2008 .

[36]  S. Natsugoe,et al.  Diagnostic value of serum peptidome analyses for protease activated pathological conditions beyond cancer diagnosis. , 2009, Medical hypotheses.

[37]  P. Tempst,et al.  Serum Peptidome Patterns That Distinguish Metastatic Thyroid Carcinoma from Cancer-free Controls Are Unbiased by Gender and Age*S , 2006, Molecular & Cellular Proteomics.

[38]  C. Schaefer,et al.  Analysis of the human serum proteome , 2004, Clinical Proteomics.

[39]  Ching-Jin Chang,et al.  Regulation of tristetraprolin during differentiation of 3T3‐L1 preadipocytes , 2007, The FEBS journal.

[40]  P. Verhaert,et al.  Matrix‐assisted laser desorption/ionization quadrupole Time‐of‐Flight Mass Spectrometry: An elegant tool for peptidomics , 2001, Proteomics.

[41]  Balwir Matharoo-Ball,et al.  Enrichment of low molecular weight serum proteins using acetonitrile precipitation for mass spectrometry based proteomic analysis. , 2008, Rapid communications in mass spectrometry : RCM.

[42]  E. Petricoin,et al.  Analysis of albumin-associated peptides and proteins from ovarian cancer patients. , 2005, Clinical chemistry.

[43]  A. Olshen,et al.  Differential exoprotease activities confer tumor-specific serum peptidome patterns. , 2005, The Journal of clinical investigation.

[44]  J. Mymryk,et al.  Roles for the coactivators CBP and p300 and the APC/C E3 ubiquitin ligase in E1A-dependent cell transformation , 2006, British Journal of Cancer.

[45]  R. Beavis,et al.  Tandem mass spectrometry of human tryptic blood peptides calculated by a statistical algorithm and captured by a relational database with exploration by a general statistical analysis system. , 2009, Journal of proteomics.

[46]  Rency S Varghese,et al.  Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma , 2006, Proteomics.

[47]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[48]  H. Tammen,et al.  Peptidomic analysis of blood plasma after in vivo treatment with protease inhibitors—A proof of concept study , 2008, Peptides.

[49]  G. Jackowski,et al.  Human serum proteins preseparated by electrophoresis or chromatography followed by tandem mass spectrometry. , 2004, Journal of proteome research.

[50]  Makarov,et al.  Electrostatic axially harmonic orbital trapping: a high-performance technique of mass analysis , 2000, Analytical chemistry.

[51]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[52]  J. Barbosa,et al.  Evaluation of on‐line solid phase extraction‐capillary electrophoresis‐electrospray‐mass spectrometry for the analysis of neuropeptides in human plasma , 2008, Electrophoresis.

[53]  Daniel W. Chan,et al.  Clinical proteomics , 2006 .

[54]  E. Holland,et al.  Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. , 2004, Analytical chemistry.

[55]  Ronald J. Moore,et al.  Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.

[56]  Ying Wang,et al.  The human plasma proteome: Analysis of Chinese serum using shotgun strategy , 2005, Proteomics.

[57]  M. Tucholska,et al.  Human serum proteins fractionated by preparative partition chromatography prior to LC-ESI-MS/MS. , 2009, Journal of proteome research.

[58]  Robertson Craig,et al.  TANDEM: matching proteins with tandem mass spectra. , 2004, Bioinformatics.

[59]  C. V. Jongeneel,et al.  Identification of cancer/testis-antigen genes by massively parallel signature sequencing , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[60]  H. Zou,et al.  Selective extraction of peptides in acidic human plasma by porous silica nanoparticles for peptidome analysis with 2-D LC-MS/MS. , 2007, Journal of separation science.

[61]  A. Shevchenko,et al.  Rapid 'de novo' peptide sequencing by a combination of nanoelectrospray, isotopic labeling and a quadrupole/time-of-flight mass spectrometer. , 1997, Rapid communications in mass spectrometry : RCM.

[62]  Eugene A. Kapp,et al.  Overview of the HUPO Plasma Proteome Project: Results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly‐available database , 2005, Proteomics.

[63]  P. Budde,et al.  Peptidomics analysis of human blood specimens for biomarker discovery , 2007, Expert review of molecular diagnostics.

[64]  G. Hortin The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome. , 2006, Clinical chemistry.

[65]  J. Yates,et al.  Method to correlate tandem mass spectra of modified peptides to amino acid sequences in the protein database. , 1995, Analytical chemistry.

[66]  T. Veenstra,et al.  Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry , 2004, Proteomics.

[67]  G. Woude,et al.  An alternatively spliced form of Met receptor is tumorigenic , 2006, Experimental & Molecular Medicine.

[68]  M. Jones,et al.  Identification and characterization of BPTF, a novel bromodomain transcription factor. , 2000, Genomics.

[69]  William E Grizzle,et al.  Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[70]  M. Schrader,et al.  Composition of the peptide fraction in human blood plasma: database of circulating human peptides. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[71]  T. Colgan,et al.  Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10. , 2004, Journal of proteome research.

[72]  David M. Conrad,et al.  Ryanodine receptor signaling is required for anti‐CD3‐induced T cell proliferation, interleukin‐2 synthesis, and interleukin‐2 receptor signaling , 2004, Journal of cellular biochemistry.

[73]  K. Coombes,et al.  Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. , 2005, Journal of proteome research.

[74]  T. McCarthy,et al.  Activation of ryanodine receptor/Ca2+ release channels downregulates CD38 in the Namalwa B lymphoma , 2003, FEBS letters.

[75]  Michael R. Green,et al.  p53-Mediated Inhibition of Angiogenesis Through Up-Regulation of a Collagen Prolyl Hydroxylase , 2006, Science.

[76]  H. Tammen,et al.  Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display , 2005, Proteomics.

[77]  David A Bennett,et al.  High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. , 2005, Clinical chemistry.

[78]  D. N. Perkins,et al.  Probability‐based protein identification by searching sequence databases using mass spectrometry data , 1999, Electrophoresis.

[79]  Xueyun Chen,et al.  Two-dimensional differential in-gel electrophoresis for identification of gastric cancer-specific protein markers. , 2009, Oncology reports.

[80]  E. Petricoin,et al.  An investigation into the human serum “interactome” , 2004, Electrophoresis.

[81]  S. Hanash,et al.  Challenges in deriving high-confidence protein identifications from data gathered by a HUPO plasma proteome collaborative study , 2006, Nature Biotechnology.

[82]  Mingliang Ye,et al.  Selective on-line serum peptide extraction and multidimensional separation by coupling a restricted-access material-based capillary trap column with nanoliquid chromatography-tandem mass spectrometry. , 2009, Journal of chromatography. A.

[83]  Bob Löwenberg,et al.  High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients. , 2003, Blood.

[84]  W. Hancock,et al.  Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. , 2006, Journal of chromatography. A.

[85]  David Fenyö,et al.  Validation of endogenous peptide identifications using a database of tandem mass spectra. , 2008, Journal of proteome research.

[86]  I. Shih,et al.  Gene Expression Signatures Differentiate Ovarian/Peritoneal Serous Carcinoma from Diffuse Malignant Peritoneal Mesothelioma , 2006, Clinical Cancer Research.

[87]  Rong Zeng,et al.  Human plasma proteome analysis by multidimensional chromatography prefractionation and linear ion trap mass spectrometry identification. , 2005, Journal of proteome research.

[88]  G. Hortin,et al.  Diverse range of small peptides associated with high-density lipoprotein. , 2006, Biochemical and biophysical research communications.

[89]  Ronald J Moore,et al.  Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. , 2004, Analytical chemistry.

[90]  J. Jonklaas,et al.  Endogenous thyrotropin and triiodothyronine concentrations in individuals with thyroid cancer. , 2008, Thyroid : official journal of the American Thyroid Association.

[91]  B. Cargile,et al.  Potential for false positive identifications from large databases through tandem mass spectrometry. , 2004, Journal of proteome research.

[92]  F. Fernández,et al.  Serum biomarker profiling by solid-phase extraction with particle-embedded micro tips and matrix-assisted laser desorption/ionization mass spectrometry. , 2008, Rapid communications in mass spectrometry : RCM.

[93]  Gilbert S Omenn,et al.  An evaluation, comparison, and accurate benchmarking of several publicly available MS/MS search algorithms: Sensitivity and specificity analysis , 2005, Proteomics.